Navigation Links
NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009
Date:3/10/2009

RONKONKOMA, N.Y., March 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the B. Riley & Co. Annual Las Vegas Institutional Investor Conference on Wednesday, March 18, 2009.

The presentation is scheduled to be webcast live on the Company Web site, www.nbty.com, on Wednesday, March 18, 2009 at 1:00PM Pacific Time (4:00PM Eastern Time).

NBTY's preliminary unaudited net sales results for February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                             FOR THE MONTH OF FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $111      $81      38%

    North American Retail                     $17      $17       1%

    European Retail                           $42      $51     -18%

    Direct Response / E-Commerce              $17      $19     -10%

    Total                                    $187     $168      12%
                                             ====     ====      ===

Wholesale / US Nutrition net sales for the month of February 2009 include $33 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 3% for the one-month period. North American Retail same store sales increased 2% for
'/>"/>

SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
2. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
3. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
4. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
5. Thoratec Presentation at Raymond James Conference to Be Webcast
6. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
7. Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results
8. Volcano Corporation Announces Webcast of February 25th Analyst Day
9. Telik Announces Year-End Financial Release, Conference Call and Webcast
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
11. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... Programming Announced in Lead Up to World AIDS Day (Dec. ... PARK, Calif., Nov. 26 For more than ten years, ... the U.S. and abroad to reach the public with information ... surrounding the disease. The Foundation,s media partnerships leverage significant ...
... 26, 2008 The American Society for Gastrointestinal ... in U.S. cancer deaths and incidence rates, with colorectal ... ASGE, representing the specialists in colorectal cancer screening, is ... among men and women dropped 4.3 percent per year ...
... of Matthew L. Myers President, Campaign for Tobacco-Free Kids ... 26 Guatemala,s Congress on November 24, 2008, approved ... places, including restaurants and bars, be 100 percent smoke-free. ... protecting the health of Guatemala,s 13 million residents and ...
... it,s cheaper and less time-consuming than in-person visits, study ... counseling may be as effective as face-to-face counseling in ... University of Florida study included 234 obese women, ages ... Florida. , All the women completed a six-month weight-loss ...
... of our genetic material--about 2%-- performs the crucial task scientists ... serve as a blueprint for the production of proteins, the ... of human DNA is converted into intermediary molecules called RNAs, ... , And what of the other 98% of the ...
... taste sensation of rats to sweet foods and drives ... neuroscientists. Findings from the Penn State study could uncover ... reveal how flab hooks the brain on sugary food., ... you tend to consume it in higher amounts," said ...
Cached Medicine News:Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 2Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 3Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 4Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 5Health News:ASGE encouraged by drop in colorectal cancer deaths 2Health News:Guatemala's Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation 2Health News:Guatemala's Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation 3Health News:Over-the-Phone Weight Loss Counseling Works 2Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 2Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 3Health News:Route to obesity passes through tongue 2Health News:Route to obesity passes through tongue 3
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... FRAMINGHAM, Mass. , Jan. 14, 2014 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that it expects revenues for the ... bringing expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... HILLSBORO, Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- ... and a targeting guide with accompanying instrumentation to place ... new adjunct to the soft tissue (e.g. ligament) repair ... soft tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... N.J. , Aug. 2 Octapharma ... from the U.S. Food and Drug Administration (FDA) ... the replacement therapy developed specifically for von Willebrand Disease (VWD). ... Products Development , which helps to advance the development of ...
... EMERYVILLE, Calif. , Aug. 2 Bionovo, ... results from studies in neurons of its drug candidate Menerba ... in the Public Library of Science (PLoS) One, describes a ... from stem cells, and express native estrogen receptors. Menerba, an ...
Cached Medicine Technology:FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 2FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 3FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 4FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 5Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 2Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 3Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 4
ReNu 1 Step Enzymatic Cleaner with ReNu Multi-Purpose Solution removes protein deposits while lenses are being disinfected. Its a one-step process that saves time. Removes stubborn deposits from dai...
...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... intraocular lenses. The instrument consists of a ... implant and divides the implant into two ... halves of the lens so that unwanted ... chamber is avoided. The instrument is passed ...
Medicine Products: